Medtronic Stock Forecast for 2022 - 2025 - 2030

Updated on 05/24/2022

Stock Rating
4 / 10
Price Target
$122.00
Consensus
Outperform
Upside
15.54%
Analysts
5
Stock Rating
4
Upside
15.54%
Analysts
5
Price Target
$122.00

The average price target of $122.00 for Medtronic's stock set by five distinguished analysts in recent weeks would represent a potential upside of approximately 15.54% from the last closing price in May, 2022 if reached by the end of the year. This potential increase is based on a high estimate of $149.00 and a low estimate of $105.00. If you're thinking of investing in MDT stock, it might be good to look at its rivals too.

$122.00

15.54% Upside

Outperform
Outperform

Medtronic Fair Value Forecast for 2022 - 2025 - 2030

Over the past three years, Medtronic's Fair Value has decreased from $87.24 to $81.21 – a 6.92% drop! Analysts predict that Medtronic's Fair Value will increase moderately in the upcoming year, reaching $105.53. This would represent an increase of 29.95%. Over the next eight years, experts predict that Medtronic's Fair Value will grow at a rate of 136.74%

2023 Fair Value Forecast
$105.53
2024 Fair Value Forecast
$116.32
2025 Fair Value Forecast
$126.75
2026 Fair Value Forecast
$134.98
2027 Fair Value Forecast
$151.08
2028 Fair Value Forecast
$163.65
2029 Fair Value Forecast
$176.99
2030 Fair Value Forecast
$192.25
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
ABBV Stock Forecast AbbVie Outperform 6
$149.11 $152.52 12.5% 19
AZN Stock Forecast AstraZeneca PLC Outperform 3
£104.94 £136.08 39% 13
ABT Stock Forecast Abbott Laboratories Outperform 7
$113.77 $141.24 23.06% 19
DHR Stock Forecast Danaher Outperform 5
$252.00 $339.17 32.94% 7
BMY Stock Forecast Bristol-Myers Squibb Outperform 8
$77.13 $76.69 1.13% 16

Medtronic Revenue Forecast for 2022 - 2025 - 2030

In the past three years, Medtronic's Revenue has seen a insignificant increase, rising from $29.95B to $30.12B. This represents a growth of 0.55%. Analysts predict that Medtronic's Revenue will increase moderately in the upcoming year, reaching $33.37B. This would represent an increase of 10.82%. Over the next eight years, experts predict that Medtronic's Revenue will grow at a rate of 65.19%

2023 Rev Forecast
$33.37B
2024 Rev Forecast
$35.12B
2025 Rev Forecast
$37.29B
2026 Rev Forecast
$39.45B
2027 Rev Forecast
$42.06B
2028 Rev Forecast
$44.51B
2029 Rev Forecast
$47.06B
2030 Rev Forecast
$49.75B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
AMGN Stock Forecast Amgen Hold 6
$251.89 $246.46 -0.75% 13
CVS Stock Forecast CVS Health Outperform 6
$96.45 $118.09 24.42% 17
GSK Stock Forecast GlaxoSmithKline Outperform 1
£17.64 £16.08 2.04% 11

Medtronic Dividend per Share Forecast for 2022 - 2025 - 2030

Medtronic's DPS has seen considerable growth in the last three years, going from $1.84 to $2.32 – a gain of 26.09% In the next year, analysts believe that DPS will reach a reasonable $2.66 – an increase of 14.66% For the next eight years, the forecast is for DPS to grow by 74.23%

2023 DPS Forecast
$2.66
2024 DPS Forecast
$2.88
2025 DPS Forecast
$3.11
2026 DPS Forecast
$3.24
2027 DPS Forecast
$3.45
2028 DPS Forecast
$3.65
2029 DPS Forecast
$3.83
2030 DPS Forecast
$4.04
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
MMM Stock Forecast 3M Hold 5
$145.75 $188.41 9.98% 17
GE Stock Forecast General Electric Outperform 2
$74.52 $121.44 43.59% 13
GILD Stock Forecast Gilead Sciences Outperform 5
$64.35 $75.96 6.45% 19

Medtronic Free Cash Flow Forecast for 2022 - 2025 - 2030

Medtronic's Free Cash Flow has seen major growth over the last three years, jumping from $3.62B to $4.89B – an increase of 35.09%. In the next year, analysts predict that Free Cash Flow will reach a reasonable $6.68B – an increase of 36.79%. For the next eight years, the forecast is for Free Cash Flow to grow by 139.49%

2023 FCF Forecast
$6.68B
2024 FCF Forecast
$7.67B
2025 FCF Forecast
$8.17B
2026 FCF Forecast
$8.88B
2027 FCF Forecast
$9.55B
2028 FCF Forecast
$10.22B
2029 FCF Forecast
$10.96B
2030 FCF Forecast
$11.70B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
BDX Stock Forecast Becton, Dickinson and Outperform 5
$257.45 $270.20 10.7% 3
EW Stock Forecast Edwards Lifesciences Outperform 5
$94.54 $127.85 37.51% 19
BSX Stock Forecast Boston Scientific Outperform 4
$40.15 $49.85 24.53% 23

Medtronic Net Income Forecast for 2022 - 2025 - 2030

In three years, Net Income for Medtronic has grown by a respectable 16.17%, going from $3.10B to $3.61B. In the coming year, analysts are expecting a significant increase in Net Income, predicting it will reach $7.73B – an increase of 114.25%. Over the next eight years, experts anticipate that Net Income growth for Medtronic will be 273.91%.

2023 NI Forecast
$7.73B
2024 NI Forecast
$8.48B
2025 NI Forecast
$9.20B
2026 NI Forecast
$9.94B
2027 NI Forecast
$10.82B
2028 NI Forecast
$11.66B
2029 NI Forecast
$12.55B
2030 NI Forecast
$13.48B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
6501 Stock Forecast Hitachi Buy 4
¥6.40k ¥0.00 24.98% 0
ALC Stock Forecast Alcon Outperform 0
CHF79.00 CHF0.00 15.3% 14
BAX Stock Forecast Baxter International Outperform 5
$73.90 $92.47 21.79% 3

Medtronic EBITDA Forecast for 2022 - 2025 - 2030

Medtronic's EBITDA has decreased moderately in the past three years, from $9.19B to $8.16B – a 11.19% drop. In the next year, analysts are expecting a moderate increase in EPS, predicting it will reach $10.19B – an increase of 24.82%. The 2030 forecast is for EBITDA to reach $16.34B or grow by 100.26%.

2023 EBITDA Forecast
$10.19B
2024 EBITDA Forecast
$11.05B
2025 EBITDA Forecast
$11.43B
2026 EBITDA Forecast
$12.61B
2027 EBITDA Forecast
$13.47B
2028 EBITDA Forecast
$14.33B
2029 EBITDA Forecast
$15.36B
2030 EBITDA Forecast
$16.34B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
BIIB Stock Forecast Biogen Outperform 4
$202.54 $287.21 12.32% 24
CERN Stock Forecast Cerner Hold 6
$94.44 $93.31 0.59% 3
4901 Stock Forecast FUJIFILM Holdings Outperform 2
¥8.64k ¥0.00 21.58% 0

Medtronic EBIT Forecast for 2022 - 2025 - 2030

In the past three years, Medtronic's EBIT has seen a medium drop, from $6.55B to $5.46B – a moderate 16.59% decrease. For next year, the 19.00 analysts predict earnings per share of $9.29B, which would mean an increase of 70.17%. Over the next eight years, the pros' prediction is EBIT of $15.84B, which would mean a 8-year growth forecast of 190.13%.

2023 EBIT Forecast
$9.29B
2024 EBIT Forecast
$10.06B
2025 EBIT Forecast
$10.82B
2026 EBIT Forecast
$11.65B
2027 EBIT Forecast
$12.73B
2028 EBIT Forecast
$13.69B
2029 EBIT Forecast
$14.73B
2030 EBIT Forecast
$15.84B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
HOLX Stock Forecast Hologic Outperform 2
$78.39 $78.91 0.78% 12
FME Stock Forecast Fresenius Medical Care AG & Co... Hold 4
56.30€ 80.66€ 16% 11
CAH Stock Forecast Cardinal Health Hold 5
$57.11 $57.23 1.56% 4

Medtronic EPS Price Prediction Forecast for 2022 - 2025 - 2030

Over the past three years, Medtronic's EPS has decreased from $4.77 to $4.44 – a 6.92% drop! Analysts predict that Medtronic's EPS will increase moderately in the upcoming year, reaching $5.77. This would represent an increase of 29.95%. Over the next eight years, experts predict that Medtronic's EPS will grow at a rate of 136.74%

2023 EPS Forecast
$5.77
2024 EPS Forecast
$6.36
2025 EPS Forecast
$6.93
2026 EPS Forecast
$7.38
2027 EPS Forecast
$8.26
2028 EPS Forecast
$8.95
2029 EPS Forecast
$9.68
2030 EPS Forecast
$10.51
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
ABMD Stock Forecast Abiomed Outperform 6
$249.19 $347.50 43.46% 7
FPH Stock Forecast Fisher & Paykel Healthcare Cor... Hold 4
$29.75 $29.99 -16.37% 1
GETI B Stock Forecast Getinge AB Outperform 2
kr286.00 kr349.27 53.85% 6

© Copyright 2022 | Stock Forecast | All Rights Reserved